203 related articles for article (PubMed ID: 20480407)
1. CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells.
Enguita-Germán M; Schiapparelli P; Rey JA; Castresana JS
Tumour Biol; 2010 Oct; 31(5):381-90. PubMed ID: 20480407
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells.
Elamin MH; Shinwari Z; Hendrayani SF; Al-Hindi H; Al-Shail E; Khafaga Y; Al-Kofide A; Aboussekhra A
Mol Carcinog; 2010 Mar; 49(3):302-14. PubMed ID: 20025076
[TBL] [Abstract][Full Text] [Related]
3. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines.
Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y
Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+ cell compartment and the in vitro tumorigenic capability of neuroblastoma cells.
Schiapparelli P; Shahi MH; Enguita-Germán M; Johnsen JI; Kogner P; Lázcoz P; Castresana JS
Cancer Lett; 2011 Nov; 310(2):222-31. PubMed ID: 21803487
[TBL] [Abstract][Full Text] [Related]
5. Activation of Sonic hedgehog signaling pathway in S-type neuroblastoma cell lines.
Zhou Y; Dai R; Mao L; Xia Y; Yao Y; Yang X; Hu B
J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):271-7. PubMed ID: 20556567
[TBL] [Abstract][Full Text] [Related]
6. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells.
Uchida H; Arita K; Yunoue S; Yonezawa H; Shinsato Y; Kawano H; Hirano H; Hanaya R; Tokimura H
J Neurooncol; 2011 Sep; 104(3):697-704. PubMed ID: 21380601
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling promotes medulloblastoma survival via Bc/II.
Bar EE; Chaudhry A; Farah MH; Eberhart CG
Am J Pathol; 2007 Jan; 170(1):347-55. PubMed ID: 17200206
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma.
Bhuria V; Xing J; Scholta T; Bui KC; Nguyen MLT; Malek NP; Bozko P; Plentz RR
Exp Cell Res; 2019 Dec; 385(2):111671. PubMed ID: 31634481
[TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells.
Wang X; Venugopal C; Manoranjan B; McFarlane N; O'Farrell E; Nolte S; Gunnarsson T; Hollenberg R; Kwiecien J; Northcott P; Taylor MD; Hawkins C; Singh SK
Oncogene; 2012 Jan; 31(2):187-99. PubMed ID: 21685941
[TBL] [Abstract][Full Text] [Related]
11. Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastoma.
Coon V; Laukert T; Pedone CA; Laterra J; Kim KJ; Fults DW
Mol Cancer Ther; 2010 Sep; 9(9):2627-36. PubMed ID: 20807782
[TBL] [Abstract][Full Text] [Related]
12. Cyclopamine sensitizes glioblastoma cells to temozolomide treatment through Sonic hedgehog pathway.
Carballo GB; Matias D; Ribeiro JH; Pessoa LS; Arrais-Neto AM; Spohr TCLSE
Life Sci; 2020 Sep; 257():118027. PubMed ID: 32622951
[TBL] [Abstract][Full Text] [Related]
13. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.
Chen X; Lingala S; Khoobyari S; Nolta J; Zern MA; Wu J
J Hepatol; 2011 Oct; 55(4):838-45. PubMed ID: 21334406
[TBL] [Abstract][Full Text] [Related]
14. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.
Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J
Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory potential of postnatal treatment with cyclopamine, a hedgehog signaling inhibitor, on medulloblastoma development in Ptch1 heterozygous mice.
Matsuo S; Takahashi M; Inoue K; Tamura K; Irie K; Kodama Y; Nishikawa A; Yoshida M
Toxicol Pathol; 2014 Dec; 42(8):1174-87. PubMed ID: 24862798
[TBL] [Abstract][Full Text] [Related]
16. Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
Steg A; Amm HM; Novak Z; Frost AR; Johnson MR
Cancer Biol Ther; 2010 Nov; 10(9):893-902. PubMed ID: 20814245
[TBL] [Abstract][Full Text] [Related]
17. Expression of sonic hedgehog signaling components in hepatocellular carcinoma and cyclopamine-induced apoptosis through Bcl-2 downregulation in vitro.
Chen XL; Cheng QY; She MR; Wang Q; Huang XH; Cao LQ; Fu XH; Chen JS
Arch Med Res; 2010 Jul; 41(5):315-23. PubMed ID: 20851287
[TBL] [Abstract][Full Text] [Related]
18. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma.
Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC
J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950
[TBL] [Abstract][Full Text] [Related]
19. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.
Blazek ER; Foutch JL; Maki G
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):1-5. PubMed ID: 17084552
[TBL] [Abstract][Full Text] [Related]
20. mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.
Matsubara S; Ding Q; Miyazaki Y; Kuwahata T; Tsukasa K; Takao S
Sci Rep; 2013 Nov; 3():3230. PubMed ID: 24231729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
